November 4, 2009
FDA Classifies Synthes' Voluntary Medical Device Recall of Synex II Central Body Components as a Class I Recall

October 21, 2009
Synthes Reports Local Currency Sales Growth of 10.0% for Third Quarter 2009 and Maintains Double-Digit Sales Growth through First Nine Months 2009